Camrelizumab/famitinib combination significantly improved PFS and OS over platinum-based chemotherapy in recurrent/metastatic ...

Mailing HPV self-sampling kits boosts cervical cancer screening completion and is more cost-effective than opt-in or ...

Panel A shows worldwide age-standardized incidence and mortality rates for cervical cancer in 2022. Data are from the GLOBOCAN database and were collated by the International Agency for Research on ...

Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal care and screening disparities. Data from 2001-2019 reveal a widening gap in ...

Camrelizumab and famitinib are projected to achieve global annual sales of $463 million and $108 million by 2031.

To coincide with Cervical Cancer Prevention Week, which starts today, cervical cancer charity Jo's Trust has launched its biggest ever campaign, aiming to 'End Cervical Cancer in the UK'. Its latest ...

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the University of California, Davis, have developed a microfluidic model of the human cervix. This ...

Picture this: You and your partner are finally getting in some sexy time (or you’re having a solo session) when all of a sudden, you feel an intense pain that can only be described as a stabbing ...

Recommended treatments, including surgery and radiotherapy, significantly improve survival rates in older patients with early-stage cervical cancer. Patients aged 65-74 who received surgery had a 91.2 ...